EDGE
Get a demo
Log In
All Updates

All Updates

icon
Filter
Partnerships
Danaher Corporation collaborates with Johns Hopkins University to enhance traumatic brain injury diagnosis
Precision Medicine
May 9, 2024
This week:
Product updates
Stability AI launches Stable Diffusion 3 Medium, a text-to-image model
Foundation Models
Yesterday
Product updates
Microsoft discontinues GPT Builder in Copilot
Generative AI Applications
Yesterday
Funding
BlinqIO raises USD 5 million in funding to expand operations
Generative AI Applications
Yesterday
Product updates
Databricks launches innovations to Mosaic AI for production-quality applications
Generative AI Infrastructure
Yesterday
M&A
Rebellions and Sapeon Korea merge to challenge global AI chip leader
Generative AI Infrastructure
Yesterday
M&A
Pluxee to acquire Cobee; expands employee benefits offering
Remote Work Infrastructure
Yesterday
Product updates
Space and Time launches 'Proof of SQL' solution on GitHub
Enterprise Blockchain Solutions
Yesterday
Partnerships
Lido partners with Mellow Finance to launch liquid restaking vaults
Decentralized Finance (DeFi)
Yesterday
Funding
Rivia raises EUR 3 million in seed funding
Clinical Trial Technology
Yesterday
Partnerships
Product updates
Databricks and Shutterstock collaborate to launch enterprise-optimized ImageAI model
Generative AI Infrastructure
Yesterday
Precision Medicine

Precision Medicine

May 9, 2024

Danaher Corporation collaborates with Johns Hopkins University to enhance traumatic brain injury diagnosis

Partnerships

  • Danaher Corporation has partnered with Johns Hopkins University to develop new methods for diagnosing mild traumatic brain injury (TBI). The development process will entail using next-generation immunoassay detection technology provided by Beckman Coulter Diagnostics, a subsidiary of Danaher.

  • The partnership intends to improve TBI diagnosis using blood-based biomarkers and advanced in vitro diagnostics technology. These techniques may potentially lead to detecting injuries earlier and more accurately to determine better treatment, outcomes, and speedy recovery. The project is part of the Danaher Beacons program, which funds scientific research in collaboration with globally recognized academic researchers.

  • Beckman Coulter Diagnostics develops novel products aimed at simplifying and automating complex biomedical tests. Its diagnostic systems are used globally in hospitals and critical care environments to assist doctors with disease diagnosis, treatment decisions, and patient monitoring.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.